2CARE HUMAN HD SERUM ANALYSES: FOX/GIGLEY LABS UNIV WYOMING
Published: 27 January 2021| Version 1 | DOI: 10.17632/mmrhhszwks.1
To investigate if latent CNS infections with common pathogens may potentiate human HD we determined seropositivity/negativity for 4 pathogens (Toxoplasma gondii, HSV1, CMV, and EBV) we also completed serum neurofilament-L analyses. We have additional data on age of onset, CAG repeat sizes, and clinical testing scores. The serum samples were obtained from the HD 2CARE clinical trial of co-enzymes Q.